Clinical Trials Browser

Phase 2 × Tablets × Tumor-Agnostic × Clear all

NCT04393454 2024-07-25

Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy

Phase 2 Terminated

6 enrolled 12 charts

Neoplasm Metastasis, Neoplasms